Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/04/1997 | WO1997045446A1 Glycine transporter-transfected cells and uses thereof |
12/04/1997 | WO1997045445A1 Protein markers for esophageal cancer |
12/04/1997 | WO1997045444A1 Ebv ctl epitopes |
12/04/1997 | WO1997045437A1 Compositions and methods for antisense inhibition of protein translation |
12/04/1997 | WO1997045144A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
12/04/1997 | WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
12/04/1997 | WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis |
12/04/1997 | WO1997045136A1 Lactoferrin variants and uses thereof |
12/04/1997 | WO1997045128A1 Apoptosis associated protein bbk |
12/04/1997 | WO1997045107A1 Remedies for brain diseases |
12/04/1997 | WO1997045106A1 Identification of genes altered in multiple myeloma |
12/04/1997 | WO1997045019A1 Buchloe dactyloides extracts having insecticidal properties |
12/04/1997 | WO1997045015A1 Modulation of opioid receptor-mediated macrophage chemotactic activity |
12/04/1997 | WO1997045000A1 Metal-regulated transporters and uses therefor |
12/04/1997 | WO1997041207A3 Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector |
12/04/1997 | WO1997041206A3 Von willebrand factor multimerase |
12/04/1997 | WO1997041150A3 Gene therapy for mitochondrial dna deffects using peptide nucleic acids |
12/04/1997 | WO1997038293A3 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
12/04/1997 | CA2257148A1 Mini-adenoviral vector |
12/04/1997 | CA2257113A1 Screen for ecdysone receptor ligands |
12/04/1997 | CA2257110A1 Screen for ultraspiracle inhibitors |
12/04/1997 | CA2256756A1 Recombinant plant genome, comprising specific chicory genes and a nucleotide sequence conferring male sterility, and its use. |
12/04/1997 | CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
12/04/1997 | CA2256577A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
12/04/1997 | CA2256498A1 Cell growth regulatory genes |
12/04/1997 | CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
12/04/1997 | CA2256455A1 Identification of genes altered in multiple myeloma |
12/04/1997 | CA2256453A1 Lactoferrin variants and uses thereof |
12/04/1997 | CA2256372A1 Apoptosis associated protein bbk |
12/04/1997 | CA2256368A1 An interleukin-5 antagonist |
12/04/1997 | CA2256358A1 Compositions and methods for antisense inhibition of protein translation |
12/04/1997 | CA2256312A1 Prion protein binding proteins and uses thereof |
12/04/1997 | CA2256310A1 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
12/04/1997 | CA2255927A1 Ebv ctl epitopes |
12/04/1997 | CA2253818A1 Mammalian tolloid-like gene and protein |
12/03/1997 | EP0810435A2 Detectable molecules, method of preparation and use |
12/03/1997 | EP0810287A1 Genes coding for proteins having acyl transfer activity |
12/03/1997 | EP0810285A2 Mutants of human Interleukin-3 |
12/03/1997 | EP0810283A2 Live attenuated RTX-procucing bacteria of the family Pasteurellaceae |
12/03/1997 | EP0810230A2 Anti-HIV antibodies used as control probes |
12/03/1997 | EP0810027A1 Adsorbent for tumor necrosis factor alpha, method of removal by adsorption, and adsorption device using said adsorbent |
12/03/1997 | EP0809996A2 Interferon conjugates |
12/03/1997 | EP0809701A1 Calcineurin regulatable adenylate cyclase |
12/03/1997 | EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same |
12/03/1997 | EP0809699A1 New chemokines expressed in pancreas |
12/03/1997 | EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6 |
12/03/1997 | EP0809697A2 Human peroxisome proliferator activated receptors gamma |
12/03/1997 | EP0809696A1 Novel allele of human histamine h2 receptor and methods of detection of h2 receptor variants |
12/03/1997 | EP0809695A1 Transcription factor - e2f-5 |
12/03/1997 | EP0809692A1 Materials and methods relating to the regulation of polypeptide production in cells |
12/03/1997 | EP0809656A1 MONOCLONAL ANTIBODY SPECIFIC FOR $g(b)A4 PEPTIDE |
12/03/1997 | EP0809655A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
12/03/1997 | EP0809654A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents |
12/03/1997 | EP0809653A1 Helicobacter pylori antigen |
12/03/1997 | EP0809650A1 Serine protease inhibitors |
12/03/1997 | EP0809649A1 HETEROLOGOUS POLYPEPTIDE PRODUCTION IN THE ABSENCE OF NONSENSE-MEDIATED mRNA DECAY FUNCTION |
12/03/1997 | EP0809648A1 Neuropeptide y receptor |
12/03/1997 | EP0809517A1 Anti-transforming growth factor-beta gene therapy |
12/03/1997 | EP0809513A1 Encapsidated recombinant poliovirus nucleic acid |
12/03/1997 | EP0809512A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
12/03/1997 | EP0809510A1 LYMPHOTOXIN-$g(a)/$g(b) COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS |
12/03/1997 | EP0809509A1 Allosteric control of nuclear hormone receptors |
12/03/1997 | EP0809508A1 Anti-obesity proteins |
12/03/1997 | EP0809507A1 Novel highly potent agonists of growth hormone releasing hormone |
12/03/1997 | EP0809500A1 Novel glucocorticoid response elements |
12/03/1997 | EP0730651A4 Surface loop structural analogues of fibroblast growth factors |
12/03/1997 | EP0720618A4 Process for the purification of basic fibroblast growth factor |
12/03/1997 | EP0689448B1 Angiogenine, and/or alpha1-microglobuline and/or complementary factor d for limiting protein secretion |
12/03/1997 | EP0600866B1 Compositions and methods for identifying biologically active molecules |
12/03/1997 | EP0590055B1 M-protein peptides of influenza virus as antiviral agents |
12/03/1997 | EP0533838B1 Nucleic acid ligands |
12/03/1997 | CN1166858A The tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
12/03/1997 | CN1166857A New E. coli mutant with suppressed organic acid production |
12/03/1997 | CN1166837A Chromosome 21 gene marker, compositions and methods using same |
12/02/1997 | US5693779 Isolated polynucleotide encoding protein useful for treating or preventing syndromes involving inappropriate tissue proliferation |
12/02/1997 | US5693778 Purified dna molecule having specified nucleotide sequence |
12/02/1997 | US5693777 DNA encoding pasteurella haemolytica PhaI restriction endonuclease and methyltransterase |
12/02/1997 | US5693776 Nucleic acids specific for Rochalimaea quintana |
12/02/1997 | US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use |
12/02/1997 | US5693774 DNA sequences involved in soraphen biosynthesis by myxobacteria |
12/02/1997 | US5693763 Antibodies to human carcinoma antigen |
12/02/1997 | US5693762 Humanized immunoglobulins |
12/02/1997 | US5693761 Genetic engineering; complementarity zones |
12/02/1997 | US5693760 Specific amino acid sequence consisting of position 2-135 includes a glycosylation site within position 96-98, binds beta-glalactoside containing moieties independent of absence of presence of calcium ions, stimulates hemagglutination |
12/02/1997 | US5693759 Human T-cell leukemia virus transcription modulators and screening assays |
12/02/1997 | US5693757 Huntingtin DNA, protein and uses thereof |
12/02/1997 | US5693756 Polypeptide alpha subunit of epithelial sodium channel |
12/02/1997 | US5693755 Construction and expression of synthetic genes encoding envelopes of human T cell leukemia virus type I |
12/02/1997 | US5693754 Inhibitory binding protein for insulin-like growth factors |
12/02/1997 | US5693753 Method of isolating βA4 peptide species ending at carboxy-terminals residue 42 using monoclonal antibody 369.2B |
12/02/1997 | US5693752 Hexapeptides of specified amino acid sequences |
12/02/1997 | US5693679 Fluorescent somatostatin |
12/02/1997 | US5693633 Angiotensin II antagonists |
12/02/1997 | US5693616 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
12/02/1997 | US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds |
12/02/1997 | US5693610 Binding agent for growth factor |
12/02/1997 | US5693609 Antidiabetic agents; extended duration of action |
12/02/1997 | US5693607 Administering to treat fibroproliferative disorders |
12/02/1997 | US5693536 Introducing wild-type mutated colorectal cancer gene into cell which has lost this function, then gene expression for antitumor activity |
12/02/1997 | US5693535 Enzymatic nucleic acid molecule which specifically cleaves rna sequence |